Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipients

Wai Lim, S.J. Chadban, S. Campbell, H. Dent, G.R. Russ, S.P. Mcdonald

    Research output: Contribution to journalArticlepeer-review

    18 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)368-376
    JournalNephrology
    Volume15
    DOIs
    Publication statusPublished - 2010

    Cite this